Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001579428 | SCV000535533 | likely benign | not provided | 2019-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001579428 | SCV000556311 | likely benign | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000569691 | SCV000671396 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001579428 | SCV001807209 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001579428 | SCV001918089 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579428 | SCV001929794 | likely benign | not provided | no assertion criteria provided | clinical testing |